KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cigna (CI) EBIT (2017 - 2025)

Cigna's EBIT history spans 8 years, with the latest figure at $132.1 billion for Q4 2025.

  • For Q4 2025, EBIT rose 2207.08% year-over-year to $132.1 billion; the TTM value through Dec 2025 reached $139.0 billion, up 4089.38%, while the annual FY2025 figure was $5.9 billion, 507.61% up from the prior year.
  • EBIT for Q4 2025 was $132.1 billion at Cigna, up from $2.6 billion in the prior quarter.
  • Across five years, EBIT topped out at $132.1 billion in Q4 2025 and bottomed at -$126.5 billion in Q4 2021.
  • The 5-year median for EBIT is $369.5 million (2022), against an average of $882.0 million.
  • The largest annual shift saw EBIT plummeted 1838.02% in 2021 before it skyrocketed 2932.94% in 2025.
  • A 5-year view of EBIT shows it stood at -$126.5 billion in 2021, then surged by 100.17% to $212.0 million in 2022, then soared by 871.7% to $2.1 billion in 2023, then plummeted by 404.42% to -$6.3 billion in 2024, then skyrocketed by 2207.08% to $132.1 billion in 2025.
  • Per Business Quant, the three most recent readings for CI's EBIT are $132.1 billion (Q4 2025), $2.6 billion (Q3 2025), and $2.3 billion (Q2 2025).